СПИСОК ЛИТЕРАТУРЫ

1. Абдуллаев, А.Г. Псевдомиксома брюшины / А.Г. Абдуллаев, Б.Е. Полоцкий, Ю.Г. Паяниди и др. // Онкогинекология. - 2012. - № 4. - C. 25-34.

2. Абдуллаев, А.Г. Циторедуктивные вмешательства в сочетании с гипертермической интраперитонеальной химиоперфузией при псевдомиксоме / А.Г.

3. Аманов, С.Б. Роль гипертермической интраоперационной интраперитонеальной химиоперфузии в комплексном лечении рецидивов злокачественных новообразований и канцероматоза брюшной полости / С.Б. Аманов, Н.А. Шаназаров, А.В. Привалов // Соврем. пробл. науки и образования. - 2013. - №6. - С. 661-668.

4. Беляев, А.М. Внутрибрюшинная химиотерапия злокачественных опухолей брюшной полости / А.М. Беляев, С.Ф. Багненко, Н.В. Рухляда. - СПб.: ЭЛБИ-СПб, 2007. - 254 с.

5. Беляева, О.А. Химиоперфузионное лечение злокачественных опухолей / О.А. Беляева, В.Г. Беспалов, К.Ю. Сенчик и др. // Медлайн экспресс. - 2011. - № 2/3. - С.58-65.

6. Беляева, О.А. Экспериментальная технология

химиоперфузионного лечения канцероматоза брюшной полости при раке яичника / О.А. Беляева, В.Г. Беспалов, К.Ю. Сенчик и др. // Вопр. онкол. - 2014. - Т.60, №1. - С. 71-78.

7. Гусейнов, К.Д. Гипертермическая интраперитонеальная химиотерапия (HIPEC) в лечении рецидивов рака яичника / К.Д. Гусейнов, А.М. Беляев, К.Ю. Сенчик и др. // Вопр. онкол. - 2014. - Т. 60, № 3. - С. 343347.

8. Давыдов, М.И. Гипертермическая интраоперационная интраперитонеальная химиотерапия при раке желудка: существует ли реальная возможность изменить прогноз? / М.И. Давыдов, М.Д. Тер-

Ованесов, Ю.В. Буйденок и др. // Вестн. РОНЦ им. Н.Н. Блохина РАМН. - 2010. - Т. 21, № 1. - С. 11-20.

9. Каприн, А.Д. Злокачественные новообразования в России в 2012 году: (заболеваемость и смертность) / А.Д.

10. Каприн, А.Д. Состояние онкологической помощи населению России в 2013 году / А.Д. Каприн, В.В. Старинский, Г.В. Петрова. - М: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России, 2014. - 234 с.

11. Китаев, А.В. Опыт применения интраоперационной гипертермической химиотерапии в лечении больных колоректальным и овариальным раком / А.В. Китаев, В.П. Петров, В.К. Зуев и др. // Сб. материалов IV межрегион. науч. - практ. конф. «Новые технологии, применение в клинической практике». - М., 2008. - С. 82-83.

12. Одишелидзе, Н.В. Значение диагностики субклинической интраперитонеальной диссеминации у больных раком желудка / Н.В. Одишелидзе, С.С. Чистяков, З.Р. Габуния // Рос. мед. журн. Приложение Онкология. 2011. - Т. 2. - С. 49.

13. Петров, В.П. Эффективность внутриполостной гипертермической химиотерапии в операциях по поводу распространенного колоректального рака / В.П. Петров, А.В. Китаев, Д.М. Турлай, Г.В. Лазарев // Вестн. Рос. воен.-мед. акад. - 2008. - №4. - С. 172.

14. Степанов, И.В. Перитонеальный канцероматоз / И.В. Степанов, Ю.М. Падеров, С.Г. Афанасьев // Сиб. онкол. журн. - 2014. - №5. - С. 45-53.

15. Тимофеева, Е.С. Изолированная химиоперфузия легкого в комбинированном лечении метастатического поражения легких: дис. ... канд. мед. наук. : 14.01.12 / Тимофеева Екатерина Сергеевна. - СПб., 2011. - 178 с.

16. Ярэма, Р.Р. Гипертермическая интраоперационная интраперитонеальная химиоперфузия в комбинированном лечении рака

желудка / Р.Р. Ярэма, Т.Г. Фецич, М.Д. Тер-Ованесов, М.А. Огорчак // Злокачеств. опухоли. - 2012. - Т. 2, № 2. - С. 122-124.

17. Alexander, H.R. Clinical results of cytoreduction and hipec for malignant peritoneal mesothelioma / H.R. Alexander, N. Hanna, J.F. Pingpank // Cancer Treat. Res. - 2007. - Vol. 134. - P. 343-355.

18. Bae, J.H. Treatment of ovarian cancer with paclitaxel- or carboplatin- based intraperitoneal hyperthermic chemotherapy during secondary surgery / J.H.

19. Bakrin, N. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for persistent and recurrent advanced ovarian carcinoma: a multicenter, prospective study of 246 patients / N. Bakrin, E. Cotte, F. Golfier et al. // Ann. Surg. Oncol. - 2012. - Vol. 19, №13. - P. 4052-4058.

20. Bakrin, N. Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer / N. Bakrin, J.M. Classe, C. Pomel et al. // J. Visc. Surg. - 2014. - Vol. 151, №5. - P. 347-353.

21. Baratti, D. Lymph node metastases in diffuse malignant peritoneal mesothelioma / D. Baratti, S. Kusamura, A.D. Cabras et al. // Ann. Surg. Oncol. - 2010. - Vol. 17, №1. - P. 45-53.

22. Benoit, L. The effect of intra-abdominal temperature on the tissue and tumor diffusion of intraperitoneal cisplatin in a model of peritoneal carcinomatosis in rats / L. Benoit, C. Duvillard, P. Rat, B. Chauffert // Chirurgie. - 1999. - Vol. 124. - P. 375-379.

23. Berreder, J. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from ovarian cancer: a multiinstitutional study of 246 patients / J. Berreder, O. Glehen, J. Habre et al. // J. Clin. Oncol. - 2009. - Vol. 27, №15, Suppl. - P. 5542.

24. Bijelic, L. The role of intraperitoneal chemotherapy in the treatment of patients with advanced gastric cancer / L. Bijelic, P.H. Sugarbaker // Ann. Ital. Chir. - 2012. - Vol. 83. - P. 224-231.

25. Bretcha-Boix, P. Cytoreductive surgery and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colonic origin: outcomes after 7 years / P. Bretcha-Boix, J. Farre-Alegre, M. Sureda et al. // Clin. Transl. Oncol. - 2010. - Vol. 12, №6. - P. 437-42.

26. Brigand, C. Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study / C. Brigand, O.

27. Brundell, S.M. The effect of lavage on intraabdominal cell burden / S.M. Brundell, K. Tucker, B. Chatterton, P.J. Hewett // Surg. Endosc. - 2002. - Vol. 16, №7. - P. 1064-1067.

28. Cashin, P.H. Intraoperative hyperthermic versus postoperative normothermic intraperitoneal chemotherapy for colonic peritoneal carcinomatosis: a case-control study / P.H. Cashin, W. Graf, P. Nygren, H. Mahteme // Ann. Oncol. Off. J. Eur. Soc. Med. Oncol./ESMO. - 2012. - Vol. 23, №10. - P. 647-652.

29. Cavaliere, R. Selective heat sensitivity of cancer cells. Biochemical and clinical studies / R. Cavaliere, E.C. Ciocatto, B.C. Giovanella et al. // Cancer. - 1967. - Vol. 20, №9. - P. 1351-1381.

30. Ceelen, W.P. Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis / W.P. Ceelen, M. Peeters, P. Houtmeyers et al. // Ann. Surg. Oncol. - 2008. - Vol. 15, №2. - P. 535-541.

31. Chan, C.H. A critical look at local-regional management of peritoneal metastasis / C.H. Chan, J.C. Cusack, D.P. Ryan // Hematol. Oncol. Clin. North Am. - 2015. - Vol. 29, №1. - P. 153-158.

32. Chan, D.L. Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy / D.L. Chan, D.L. Morris, A. Rao, T.C. Chua // Cancer Manag. Res. - 2012. - Vol. 4, №23. - P. 413-422.

33. Cheong, J.H. Early postoperative intraperitoneal chemotherapy following cytoreductive surgery in patients with very advanced gastric cancer / J.H. Cheong, J.Y. Shen, C.S. Song et al. // Ann. Surg. Oncol. - 2007. - Vol. 14, №1. - P. 61-68.

34. Chua, T.C. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy / T.C. Chua, B.J. Moran, P.H. Sugarbaker et al. // J. Clin. Oncol. - 2012. - Vol. 30, №20. - P. 2449-2456.

35. Chua, T.C. Establishing evidence for change in ovarian cancer surgery

- proposing clinical trials of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer peritoneal carcinomatosis / T.C. Chua, W. Liauw, Robertson G. et al. // Gynecol. Oncol. - 2009. - Vol. 115.

- P. 166-168.

36. Chua, T.C. Influence of modern systemic therapies as adjunct to cytoreduction and perioperative intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis: a multicenter study / T.C. Chua, D.L. Morris, A. Saxena et al. // Ann. Surg. Oncol. - 2011. - Vol. 18, №6. - P. 1560-1567.

37. Chua, T.C. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience / T.C. Chua, T.D. Yan, D.L. Morris // J. Surg. Oncol. - 2009. - Vol. 99, №2. - P. 109-113.

38. Cotte, E. Cytoreductive surgery and intraperitoneal chemo- hyperthermia for chemoresistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients / E. Cotte, O. Glehen, F. Mohamed et al. // World J. Surg. - 2007. - Vol. 31. - P. 1813-1820.

39. Cunningham, D. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer / D. Cunningham, W.H. Allum, S.P. Stenning et al. // N. Engl. J. Med. - 2006. - Vol. 355, № 1. - P. 11-20.

40. Da Silva, R.G. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer / R.G. da Silva, P.H. Sugarbaker // J. Am. Coll. Surg. - 2006. - Vol. 203, №6. - P. 878-886.

41. De Bree, E. Experimental and pharmacokinetic studies in intraperitoneal chemotherapy: From laboratory bench to bedside / E. de Bree, D.D. Tsiftsis // Recent Results Cancer Res. - 2007. - Vol. 169. - P. 53-73.

42. De Bree, E. Hyperthermic intraperitoneal chemotherapy in ovarian cancer: rationale and clinical data / E. de Bree, C.W.

43. Deraco, M. Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer / M. Deraco, D. Baratti, B. Laterza et al. // Eur. J. Surg. Oncol. - 2011. - Vol. 37, №1. - P. 4-9.

44. Deraco, M. The Role of Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy / M. Deraco, D. Baratti, I. Hutanu et al. // Ann. Surg. Oncol. - 2013. - Vol. 20, №4. - P. 1093-1100.

45. Di Giorgio, A. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer / A. di Giorgio, E. Naticchioni, D. Biacchi et al. // Cancer. - 2008. - Vol. 113, №2. - P. 315-325.

46. Elias, D. A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendix / D. Elias, O. Glehen, M. Pocard et al. // Ann. Surg. - 2010. - Vol. 251, №5. - P. 896-901.

47. Elias, D. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin / D. Elias, J.H. Lefevre, J. Chevalier et al. // J. Clin. Oncol. - 2009. - Vol. 27, №5. - P. 681-685.

48. Elias, D. Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy / D. Elias, V. Bedard, T. Bouzid et al. // Gastroenterol. Clin. Biol. - 2007. - Vol. 31. - P. 784-788.

49. Elias, D. Peritoneal carcinomatosis of colorectal origin: long-term results of intraperitoneal chemotherapy with oxaliplatin following complete cytoreductive surgery / D. Elias, B. Raynard, F. Farkhondeh et al. // Gastroenterol. Clin. Biol. - 2006. - Vol. 30. - P. 1200-1204.

50. Elias, D. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study / D. Elias, F. Gilly, F. Boutitie et al. // J. Clin. Oncol. - 2010. - Vol. 28, №1. - P. 63-68.

51. Elias, D. Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy / D. Elias, F. Gilly, F. Quenet et al. // Eur. J. Surg. Oncol. - 2010. - Vol. 36, №5. - P. 456-462.

52. Elias, D. Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection / D. Elias, S. Antoun, A. Goharin et al. // Int. J. Surg. Investig. - 2000. - Vol. 1. - P. 431-439.

53. Faris, J.E. Controversy and consensus on the management of patients with pseudomyxoma peritonei / J.E. Faris, D.P. Ryan // Curr. Treat. Options Oncol. - 2013. - Vol.14, №3. - P. 365-373.

54. Feldman, A.L. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy / A.L. Feldman, S.K. Libutti, J.F. Pingpank et al. // J. Clin. Oncol. - 2003. - Vol. 21, №24. - P. 4560-4567.

55. Franko, J. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis / J. Franko, Z. Ibrahim, N.J. Gusani et al. // Cancer. - 2010. - Vol. 116, №16. - P. 3756-3762.

56. Frost, D.B. Small bowel cancer: a 30-year review / D.B. Frost, P.D. Mercado, J.S. Tyrell // Ann. Surg. Oncol. - 1994. - Vol. 1, №4. - P. 290-295.

57. Fujiwara, K. Principle and evolving role of intraperitoneal chemotherapy in ovarian cancer / K. Fujiwara, S. Nagao, E. Aotani // Expert. Opin. Pharmacother. - 2013. - Vol. 14, №13. - P. 1797-1806.

58. Garcia Carbonero, R. Systemic chemotherapy in the management of malignant peritoneal mesothelioma / R. Garcia Carbonero, L. Paz-Ares // Eur. J. Surg. Oncol. - 2006. - Vol. 32, №6. - P. 676-81.

59. Gill, R.S. Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity / R.S. Gill, D.P. Al-Adra, J. Nagendran et al. // J. Surg. Oncol. - 2011. - Vol. 104, №6. - P. 692-698.

60. Glehen, O. Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer / O. Glehen, V. Schreiber, E. Cotte et al. // Arch. Surg. - 2004. - Vol. 139, №1. - P. 20-26.

61. Glehen, O. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study / O. Glehen, F. Kwiatkowski, P.H. Sugarbaker et al. // J. Clin. Oncol. - 2004. - Vol. 22, № 16. - P. 3284-3292.

62. Glehen, O. Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion / O. Glehen, E. Cotte, S. Kusamura et al. // J. Surg. Oncol. - 2008. - Vol. 98. - P. 242-246.

63. Glehen, O. Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin / O. Glehen, E. Cotte, V. Schreiber et al. // Br. J. Surg. - 2004. - Vol. 91. - P. 747-754.

64. Glehen, O. Peritoneal carcinomatosis from gastric cancer: a multiinstitutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy / O. Glehen, F.N. Gilly, C. Arvieux et al. // Ann. Surg. Oncol. - 2010. - Vol. 17, №9. - P. 2370-2377.

65. Gonzalez-Moreno, S. Hyperthermic intraperitoneal chemotherapy. Methodology and safety considerations / S. Gonzalez-Moreno, Gonzalez-Bayon

L. , Ortega-Perez G. // Surg. Oncol. Clin. N. Am. - 2012. - Vol. 21. - P. 543-557.

66. Gonzalez-Moreno, S. Hyperthermic intraperitoneal chemotherapy: Rationale and technique / S. Gonzalez-Moreno, L.A. Gonzalez-Bayon, G. Ortega- Perez // World J. Gastrointest. Oncol. - 2010. - Vol. 2, №2. - P. 68-75.

67. Gough, D.B. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach / D.B. Gough, J.H. Donohue, A.J. Schutt et al. // Ann. Surg. - 1994. - Vol. 219, №2. - P. 112-119.

68. Hall, J.J. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer / J.J. Hall, B.W. Loggie, P. Shen et al. // J. Gastrointest. Surg. - 2004. - Vol. 8,№4. - P. 454-463.

69. Hansen, E. Tumor cells in blood shed from the surgical field / E. Hansen, N. Wolff, R. Knuechel et al. // Arch. Surg. - 1995. - Vol. 130, №4. - P. 387-393.

70. Helm, C.W. HIPEC in ovarian cancer: first report of HYPER-O registry / C. W. Helm, S. D. Richard, J. Pan et al. // Int. J. Gynecol. Cancer. - 2010. - Vol. 20, №1. - P. 61-69.

71. Helm, C.W. The role of hyperthermic Intraperitoneal chemotherapy (HIPEC) in ovarian cancer / C.W. Helm // Oncologist. - 2009. - Vol. 14, №7. - P. 683-694.

72. Kecmanovic, D.M. Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy / D.M. Kecmanovic, M.J. Pavlov, M.S. Ceranic et al. // Eur. J. Surg. Oncol. - 2005. - Vol. 31. - P. 147-152.

73. Kianmanesh, R. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases / R. Kianmanesh, S. Scaringi, J.M. Sabate et al. // Ann. Surg. - 2007. - Vol. 245. - P. 597-603.

74. Kitayama, J. Intraperitoneal chemotherapy against peritoneal carcinomatosis. Current status and future perspective / J. Kitayama // Surg. Oncol. - 2014. - Vol. 23, №2. - P. 99-106.

75. Koppe, M.J. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies / M.J. Koppe, O.C. Boerman, W.J. Oyen, R.P. Bleichrodt // Ann. Surg. - 2006. - Vol. 243, №2. - P. 212-222.

76. Kuramoto, M. Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma / M. Kuramoto, S. Shimada, S. Ikeshima et al. // Ann. Surg. - 2009. - Vol. 250, №2. - P. 242-246.

77. Langer, C.J. Intraperitoneal cisplatin and etoposide in peritoneal mesothelioma: Favorable outcome with a multimodality approach / C.J. Langer, N. Rosenblum, M. Hogan et al. // Cancer Chemother. Pharmacol. - 1993. - Vol. 32. - P. 204-208.

78. Levine, E.A. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures / E.A. Levine, J.H. Stewart, G.B. Russell et al. // J. Am. Coll. Surg. - 2007. - Vol. 204, №1. - P. 943-955.

79. Lieu, C.H. Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix / C.H. Lieu, L.A. Lambert, R.A. Wolff et al. // Ann. Oncol. - 2012. - Vol. 23, №3. - P. 652-628.

80. Loggie, B.W. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin / B.W. Loggie, R.A. Fleming, R.P. McQuellon et al. // Am. Surg. - 2000. - Vol. 66, №6.

- P. 561.

81. Losa, F. Cytoreductive surgery and intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis from colorectal origin / F. Losa, P. Barrios, R. Salazar et al. // Clin. Trans. Oncol. - 2013. [Электронный ресурс]. URL: http://link.springer.com/article/10.1007%2Fs12094-013-1053-x (дата обращения: 08.09.2013).

82. Lu, Z. Intraperitoneal therapy for peritoneal cancer / Z. Lu, J. Wang,

M. Guilaume Wientjes, J. Au // Future Oncol. - 2010. - Vol. 6, №10. - P. 16251641.

83. Marchettini, P. Mucinous adenocarcinoma of the small bowel with peritoneal seeding / P. Marchettini, P.H. Sugarbaker // Eur. J. Surg. Oncol. - 2002.

- Vol. 28, №1. - P. 19-23.

84. Markman, M. Efficacy of cisplatin-based intraperitoneal

chemotherapy as treatment of malignant peritoneal mesothelioma / M. Markman, D. Kelsen // J. Cancer Res. Clin. Oncol. - 1992. - Vol. 118, №7. - P. 547-550.

85. McBride, K. Improved survival of patients with pseudomyxoma peritonei receiving intraperitoneal chemotherapy with cytoreductive surgery: a systematic review and meta-analysis / K. McBride, D. McFadden, T. Osler // J. Surg. Res. - 2013. - Vol. 183, №1. - P. 246-252.

86. Miner, T.J. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy / T.J. Miner, J. Shia, D.P. Jaques et al. // Ann. Surg. - 2005. - Vol. 241, №2. - P. 300-308.

87. Nissan, A. evidence-based medicine in the treatment of peritoneal carcinomatosis: Past, Present, and Future / A. Nissan // J. Surg. Oncol. - 2009. - Vol. 100, №4. - P. 335-344.

88. North, J.H. Malignant tumors of the small intestine: a review of 144 cases / J.H. North, M.S. Pack // Am. Surg. - 2000. - Vol. 66, №1. - P. 46-51.

89. Overgaard, J. Effect of hyperthermia on malignant cells in vivo. A review and a hypothesis / J. Overgaard // Cancer. - 1977. - Vol. 39, №6. - P. 2637-2646.

90. Panarelli, N.C. Mucinous neoplasms of the appendix and peritoneum / N.C. Panarelli, R.K. Yantiss // Arch. Pathol. Lab. Med. - 2011. - Vol. 135, №10.

- P. 1261-1268.

91. Pavlov, M.J. Cytoreductive surgery and modified heated intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer - 12-year single center experience / M.J. Pavlov, P.A. Kovacevic, M.S. Ceranic et al. // Eur. J. Surg. Oncol. - 2009. - Vol. 35, №11. - P. 1186-1191.

92. Pestieau, S.R. Impact of carrier solutions on pharmacokinetics of intraperitoneal chemotherapy / S. R. Pestieau, K. J. Schnake, O. A. Stuart, et al. // Cancer Chemother. Pharmacol. - 2001. - Vol. 47, №3. - P. 269-276.

93. Peto, J. The European mesothelioma epidemic / J. Peto, A. Decarli, C. La Vecchia et al. // Br. J. Cancer. - 1999. - Vol. 79, №3. - P. 666-672.

94. Pilati, P. Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma / P. Pilati, S. Mocellin, C.R. Rossi et al. // Ann. Surg. Oncol. - 2003. - Vol. 10, №5. - P. 508-513.

95. Raspagliesi, F. Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: the experience of National Cancer Institute of Milan / F. Raspagliesi, S. Kusamura, J.C. Campos Torres et al. // Eur. J. Surg. Oncol. - 2006. - Vol. 32, №6.

- P. 671-675.

96. Rat, P. Intraperitoneal chemohypertehrmia with “overflow” open abdomen / P. Rat, L. Benoit, N. Cheynel et al. // Ann. Chir. - 2001. - Vol. 126, №7. - P. 669-671.

97. Ripley, R.T. Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases / R.T. Ripley, J.L. Davis, C.D. Kemp et al. // Trials. - 2010. - Vol. 11. [Электронный ресурс]. URL: http://www.ncbi.nlm.nih.gov/pubmed/20500867 (дата обращения: 13.06.2014).

98. Ross, P. Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer / P. Ross, M. Nicolson, D. Cunningham et al. // J. Clin. Oncol. - 2002. - Vol. 20, №8. - P. 1996-2004.

99. Roviello, F. Prospective study of peritoneal recurrence after curative surgery for gastric cancer / F. Roviello, D. Marrelli, G. de Manzoni et al. // Br. J. Surg. - 2003. - Vol. 90, №9. - P. 1113-1119.

100. Rufian, S. Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer / S. Rufian, F.C. Munoz-Casares, J. Briceno et al. // J. Surg. Oncol. - 2006. - Vol. 94, №4. - P. 316- 324.

101. Ryu, K.S. Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer / K.S. Ruy, J.H. Kim, H.S. Ko et al. // Gynecol. Oncol. 2004. - Vol. 94, №2. - P. 325-332.

102. Sadeghi, B. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study / B. Sadeghi, C. Arvieux, O. Glehen et al. // Cancer. - 2000. - Vol. 88, №2. - P. 358363.

103. Shen, P. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma / P. Shen, J. Hawksworth, J. Lovato et al. // Ann. Surg. Oncol. - 2004. - Vol. 11, №2. - P. 178-186.

104. Shen, P. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: non-colorectal indications / P. Shen, J.H. Stewart 4^th, E.A. Levine // Curr. Probl. Cancer. - 2009. - Vol. 33, №3. - P. 168-193.

105. Smeenk, R.M. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study / R.M. Smeenk, M.L. van Velthuysen, V.J. Verwaal, F.A. Zoetmulder // Eur. J. Surg. Oncol. - 2008. - Vol. 34, №2. - P. 196201.

106. Smeenk, R.M. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy / R.M. Smeenk, V.J. Verwaal, N. Antonini, F.A. Zoetmulder // Ann. Surg. - 2007. - Vol. 245, №1. - P.104-109.

107. Sticca, R.P. Rationale for hyperthermia with intraoperative intraperitoneal chemotherapy agents / R.P. Sticca, B.W. Dach // Surg. Oncol. Clin.

N. Am. - 2003. - Vol. 12, №3. - P. 689-701.

108. Sugarbaker, P. H. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis / P. H. Sugarbaker // Semin. Surg. Oncol. - 1988. - Vol. 14, №3. - P. 254-261.

109. Sugarbaker, P. H. Management of peritoneal-surface malignancy: the surgeon's role / P. H. Sugarbaker // Langenbecks Arch. Surg. - 1999. - Vol. 384, №6. - P. 576-587.

110. Sugarbaker, P. Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology / P. Sugarbaker // Cancer. Treat. Res. - 1996. - Vol. 82. - P. 79-100.

111. Sugarbaker, P.H. Comprehensive management of diffuse malignant peritoneal mesothelioma / P.H. Sugarbaker, T.D. Yan, O.A. Stuart, D. Yoo // Eur. J. Surg. Oncol. - 2006. - Vol. 32, №6. - P. 686-691.

112. Sugarbaker, P.H. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis / P.H. Sugarbaker // Semin. Surg. Oncol. - 1998. - Vol. 14, №3. - P. 254-261.

113. Sugarbaker, P.H. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy / P.H. Sugarbaker, D. Chang // Ann. Surg. Oncol. - 1999. - Vol. 6, №8. - P. 727-731.

114. Sugarbaker, P.H. Technical handbook for the integration of cytoreductive surgery and perioperative intraperitoneal chemotherapy into the surgical management of gastrointestinal and gynecologic malignancy / P.H. Sugarbaker. -Grand Rapids (MI): The Ludann Company, 2005. - 67 p.

115. Sun, Y. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma / Y. Sun, P. Shen, J.H. Stewart et al. // Am. Surg. - 2013. - Vol. 79, №6. - P. 644-648.

116. Talamonti, M.S. Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management / M.S. Talamonti, L.H. Goetz, S. Rao, R.J. Joehl // Arch. Surg. - 2002. - Vol. 137, №5. - P. 564-570.

117. Tan, G.H. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma / G.H. Tan, M. Cheung, J. Chanyaputhipong et al. // Ann. Acad. Med. Singapore. - 2013. - Vol. 42, №6. - P. 291-296.

118. Tentes, A.A. Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy in the treatment of advanced epithelial ovarian cancer / A.A. Tentes, S. Kakolyris, D. Kyziridis, C. Karamveri // J. Oncol.

- 2012. - Vol. 2012. [Электронный ресурс]. URL:

http://www.hindawi.com/journals/jo/2012/358341/ (дата обращения: 18.05.2014).

119. Terzi, C. Peritoneal carcinomatosis of gastrointestinal tumors: where are we now? / C. Terzi, N.C. Arslan, A.E. Canda // World J. Gastroenterol. - 2014.

- Vol. 20, №39. - P. 14371-14380.

120. Turaga, K. et al. Consensus Guidelines from the American Society of peritoneal surface malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy in colorectal cancer patients in the United States / K. Turaga, E. Levine, R. Barone et al. // Ann. Surg. Oncol. - 2013. - [Электронный ресурс]. URL: http://link.springer.com/article/10.1245%2Fs10434-013-3061-z (дата обращения: 26.06.2014).

121. Ung, L. Cure for peritoneal metastases? An evidence-based review /

L. Ung, T.C. Chua, D.L. Morris // ANZ J. Surg. - 2013. [Электронный ресурс] URL: http://onlinelibrary.wiley.com/doi/10.1111/ans. 12306/abstract (дата

обращения: 27.04.2014).

122. Vaira, M. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years / M. Varia, T. Cioppa, S. D’Amico et al. // In Vivo. - 2010. - Vol. 24. - P. 79-84.

123. Valtonen, M. New mini-extracorporeal circulation system (ECC.O) is a safe technique in coronary surgery / M. Valtonen, T. Vahasilta, T. Kaila- Keinanen, K. Kutilla // Scand. Cardiovasc. J. - 2007. - Vol. 45, №1. - P. 345-350.

124. Van Cutsem, E. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group / E. Van Cutsem, V.M. Moiseyenko, S. Tjulandin et al. // J. Clin. Oncol. - 2006. - Vol. 24, №31. - P. 4991-4997.

125. Verwaal, V.J. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer / V.J. Verwaal, S. Bruin, H. Boot et al. // Ann. Surg. Oncol. - 2008. - Vol. 15, №9. - P. 2426-2432.

126. Verwaal, V.J. Long-term survival of peritoneal carcinomatosis of colorectal origin / V.J. Verwaal, S. van Ruth, A. Witkamp et al. // Ann. Surg. Oncol. - 2005. - Vol. 12, №1. - P. 65-71.

127. Verwaal, V.J. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative Tsurgery in patients with peritoneal carcinomatosis of colorectal cancer / V.J. Verwaal, S. van Ruth, E. de Bree et al. // J. Clin. Oncol. - 2003. - Vol. 21. - P. 3737-3743.

128. Weiss, L.M. Sinusoidal hematolymphoid malignancy ("malignant histiocytosis") presenting as atypical sinusoidal proliferation. A study of nine cases / L.M. Weiss, R. Azzi, R.F. Dorfman, R.A. Warnke // Cancer. - 1986. - Vol. 58, №8. - P. 1681-1688.

129. Witkamp, A.M. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy / A.M. Witkamp, E. de Bree, A.R. Van Goethem, A.N. Zoetmulder // Cancer Treat. Rev. - 2001. - Vol. 27, №6. - P. 365374.

130. Woopen, H. Current and future options in the treatment of Malignant Ascites in ovarian cancer / H. Woopen, J. Sehouli // Anticancer Research. - 2009. - Vol. 29, №8. - P. 3353-3360.

131. Yan, T.D. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience / T.D. Yan, M. Deraco, D. Baratti et al. // J. Clin. Oncol. - 2009. - Vol. 27, №36. - P. 6237-6242.

132. Yan, T.D. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care? / T.D. Yan, D.L. Morris // Ann. Surg. - 2008. - Vol. 248, №5. - P. 829-835.

133. Yang, X.J. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial / X.J. Yang, C.Q. Huang, T. Suo et al. // Ann. Surg. Oncol. - 2011. - Vol. 18, №6. - P. 15751581.

134. Yang, X.J. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: results from a Chinese center / X.J. Yang, Y. Li, Y. Yonemura // J. Surg. Oncol. - 2010. - Vol. 101. - P. 457-464.

135. Yano, H. Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma / H. Yano, B.J. Moran, T.D. Cecil, E.M. Murphy // Eur. J. Surg. Oncol. - 2009. - Vol. 35, №9. - P. 980-985.

136. Yonemura, Y. A new surgical approach (peritonectomy) for the treatment of peritoneal dissemination / Y. Yonemura, T. Fujimuta, S. Fushida et al. // Hepatogastroenterology. - 1999. - Vol. 46, №25. - P. 601-609.

137. Yonemura, Y. Molecular mechanisms of peritoneal dissemination / Y. Yonemura, Y. Endou // Nihon Shokakibyo Gakkai Zasshi. - 2000. - Vol. 97, №6. - P. 680-690.

138. Yonemura, Y. Prognostic factors of peritoneal metastases from colorectal cancer following cytoreductive surgery and perioperative chemotherapy / Y. Yonemura, E. Canbay , H. Ishibashi // Sci. World J. - 2013. - Vol. 2013. [Электронный ресурс]. URL: http://www.ncbi.nlm.nih.gov/pubmed/23710154 (дата обращения: 12.07.2014).

139. Yonemura, Y. The natural history of free cancer cells in the peritoneal cavity / Y. Yonemura, T. Kawamura, E. Bandou et al. // Recent Results Cancer Res. - 2007. - Vol. 169. - P. 11-23.

140. Yonemura, Y. Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion / Y.

Yonemura, T. Kawamura, E. Bandou et al. // Br. J. Surg. - 2005. - Vol. 92, №3. - P. 370-375.

141. Zanon, C. Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovariancancer / C. Zanon, R. Clara, I. Chiappino et al. // World. J. Surg. - 2004. - Vol. 28, №10. - P. 1040-1045.

142. Zanon, C. Cytoreductive surgery combined with intraperitoneal chemohyperthermia for the treatment of advanced colon cancer / C. Zanon, M. Bortolini, I. Chiappino et al. // World J. Surg. - 2006. - Vol. 30, №11. - P. 20252032.